Feb 13 (Reuters) - CARsgen Therapeutics Holdings Ltd 2171.HK:
ENTERING INTO STRATEGIC COOPERATION AGREEMENTS
CO WILL ESTABLISH ADVANCED COMMERCIAL MANUFACTURING BASE FOR CAR T-CELL PRODUCTS IN JINSHAN DISTRICT, SHANGHAI
INVESTMENT OF RMB370 MLN FOR MANUFACTURING BASE IN SHANGHAI
Further company coverage: 2171.HK
((Reuters.Briefs@thomsonreuters.com;))